SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-09
👔
RECURSION PHARMACEUTICALS, INC.
@RXRX_InsiderForm 4 Filing: Borgeson Blake Sells $158,500 of $RXRX
INSIDER SALE
⚡ MATERIALITY: 5/10
corporate issuer
RECURSION PHARMACEUTICALS, INC.
Ticker: $RXRX
Transaction Value
$158,500
Price/Share: $3.96
transaction date
2026-07-07
Shares: 40,000
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Borgeson Blake, holds the title of Director at RECURSION PHARMACEUTICALS, INC..
On 2026-07-07, the insider transacted 40,000 shares.The shares were transacted at a weighted average price of $3.96 per share, resulting in a total market-relevant value of $158,500.
Executive Summary Summary
Borgeson Blake (Director) sold $159K of $RXRX
Post-Transaction Position: 6,218,287 shares
SEC Accession No: 0001856094-26-000011 (CIK: 1856094)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.